These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8021776)

  • 1. Surfactant therapy in extremely premature infants.
    Bose C; McCaffrey M
    J Pediatr; 1994 Jul; 125(1):173; author reply 173-4. PubMed ID: 8021776
    [No Abstract]   [Full Text] [Related]  

  • 2. Surfactant therapy in extremely premature infants.
    Merritt TA
    J Pediatr; 1994 Jul; 125(1):172-3; author reply 173-4. PubMed ID: 8021775
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival and follow-up of infants born at 23 to 26 weeks of gestational age: effects of surfactant therapy.
    Ferrara TB; Hoekstra RE; Couser RJ; Gaziano EP; Calvin SE; Payne NR; Fangman JJ
    J Pediatr; 1994 Jan; 124(1):119-24. PubMed ID: 8283360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pumactant and poractant alfa in respiratory distress syndrome.
    Morley C
    Lancet; 2000 Aug; 356(9231):765; author reply 766. PubMed ID: 11085710
    [No Abstract]   [Full Text] [Related]  

  • 5. Pumactant and poractant alfa in respiratory distress syndrome.
    Wardhaugh AD; Matthes JW
    Lancet; 2000 Aug; 356(9231):765-6. PubMed ID: 11085711
    [No Abstract]   [Full Text] [Related]  

  • 6. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants.
    Wang H; Gao X; Liu C; Yan C; Lin X; Yang C; Lin Z; Zhu W; Yang Z; Yu F; Qiu Y; Liu X; Zhou X; Chen C; Sun B;
    Pediatrics; 2012 Mar; 129(3):e731-40. PubMed ID: 22331337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous surfactant administration during the transport of premature infants.
    Riek KM
    Air Med J; 2004; 23(5):8-9. PubMed ID: 15337930
    [No Abstract]   [Full Text] [Related]  

  • 8. Surfactant. Evolving issues.
    Kattwinkel J
    Clin Perinatol; 1998 Mar; 25(1):17-32. PubMed ID: 9523072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surfactant therapy of premature infants. Complications and mortality are reduced].
    Hjalmarson O
    Lakartidningen; 1993 Nov; 90(45):3938-40. PubMed ID: 8231562
    [No Abstract]   [Full Text] [Related]  

  • 10. Does prophylactic use of bovine surfactant change drug utilization in very premature infants during neonatal period?
    Gortner L; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL
    Dev Pharmacol Ther; 1991; 16(1):1-6. PubMed ID: 1879246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous surfactant therapy for premature infants.
    Boeckling AC
    J Perinat Neonatal Nurs; 1992 Sep; 6(2):59-66. PubMed ID: 1403772
    [No Abstract]   [Full Text] [Related]  

  • 12. Surfactant replacement in preterm infants with respiratory distress syndrome.
    Dani C
    Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant therapy: past, present and future.
    Speer CP; Sweet DG; Halliday HL
    Early Hum Dev; 2013 Jun; 89 Suppl 1():S22-4. PubMed ID: 23809343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of infants 23-26 weeks' gestation pre and post surfactant.
    Jacobs SE; O'Brien K; Inwood S; Kelly EN; Whyte HE
    Acta Paediatr; 2000 Aug; 89(8):959-65. PubMed ID: 10976839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant replacement therapy in premature babies with respiratory distress syndrome: factors affecting the response to surfactant and comparison of outcome from 1982-86 and 1987-91.
    Konishi M; Chida S; Shimada S; Kasai T; Murakami Y; Cho K; Fujii Y; Maeta H; Fujiwara T
    Acta Paediatr Jpn; 1992 Dec; 34(6):617-30. PubMed ID: 1285509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant replacement therapy: a second look.
    Lynam LE
    Neonatal Netw; 1990 Oct; 9(3):79-81. PubMed ID: 2215450
    [No Abstract]   [Full Text] [Related]  

  • 17. Pumactant and poractant alfa surfactant treatment.
    Gillespie L; Madar J
    Lancet; 2000 Jul; 356(9224):167-8. PubMed ID: 10963277
    [No Abstract]   [Full Text] [Related]  

  • 18. The 5 W's of surfactant for respiratory distress syndrome of the premature infant.
    Parmigiani S
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():25-7. PubMed ID: 15590430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In response to mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study.
    Egan EA
    J Perinatol; 2013 Feb; 33(2):165-6. PubMed ID: 23361501
    [No Abstract]   [Full Text] [Related]  

  • 20. [Surfactant therapy in respiratory distress syndrome; a review].
    de Winter JP; van Sonderen L; Egberts J; van Bel F
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2010-3. PubMed ID: 1407190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.